Conditions: Pulmonary Disease, Chronic Obstructive
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 646
Healthy volunteers: no

Brief summary:
The purpose of the study is to investigate the efficacy and safety of fluticasone furoate/vilanterol Inhalation Powder compared with placebo over a 24 weeks treatment period in subjects of Asian ancestry with Chronic Obstructive Pulmonary Disease (COPD).

Detailed description:

Arms:
arm 1: Inhaled corticosteroid/long acting beta-agonist arm 2: matching placebo

Interventions: intervention 1: fluticasone furoate/vilanterol intervention 2: Placebo
Intervention descriptions: intervention 1: Inhaled corticosteroid/long acting beta-agonist intervention 2: matching placebo

Protocol document: